KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Assets Average (2019 - 2025)

Historic Assets Average for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to $493.6 million.

  • Adaptive Biotechnologies' Assets Average fell 1365.52% to $493.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $493.6 million, marking a year-over-year decrease of 1365.52%. This contributed to the annual value of $600.3 million for FY2024, which is 2090.2% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Assets Average stood at $493.6 million, which was down 1365.52% from $503.7 million recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Assets Average registered a high of $1.1 billion during Q1 2021, and its lowest value of $493.6 million during Q3 2025.
  • Moreover, its 5-year median value for Assets Average was $778.0 million (2023), whereas its average is $761.9 million.
  • Per our database at Business Quant, Adaptive Biotechnologies' Assets Average soared by 2245.53% in 2021 and then crashed by 2286.05% in 2024.
  • Adaptive Biotechnologies' Assets Average (Quarter) stood at $958.0 million in 2021, then decreased by 9.14% to $870.4 million in 2022, then dropped by 20.8% to $689.4 million in 2023, then decreased by 20.38% to $548.9 million in 2024, then dropped by 10.08% to $493.6 million in 2025.
  • Its last three reported values are $493.6 million in Q3 2025, $503.7 million for Q2 2025, and $525.1 million during Q1 2025.